MARK L PERRY Insider Trading Transactions

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for MARK L PERRY.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of MARK L PERRY. MARK L PERRY is Director in ARCA biopharma, Inc. ($ABIO) and Director in NVIDIA CORP ($NVDA) and Director in MyoKardia Inc ($MYOK) and Director in Global Blood Therapeutics, Inc. ($GBT).

Latest Insider Trading Transactions of MARK L PERRY

1 Week2 Weeks1 Month3 Months6 Months1 Year2 Years
No. of Purchases0000000
Value of Purchases ($)0000000
No. of Sales0000000
Value of Sales ($)0000000

Sentiment: All, ABIO, GBT, MYOK, NVDA

Page:   1

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Apr 06 2021NVDANVIDIA CORPPERRY MARK LDirectorSellS556.981,400779,7726,6318 K to 6.6 K (-17.43 %)
Apr 06 2021NVDANVIDIA CORPPERRY MARK LDirectorSellS556.464,7042,617,5888,03112.7 K to 8 K (-36.94 %)
Nov 19 2020MYOKMyoKardia, Inc.PERRY MARK LDirectorOption ExerciseD100.273,000300,8100
Nov 19 2020MYOKMyoKardia, Inc.PERRY MARK LDirectorOption ExerciseD47.776,600315,2820
Nov 19 2020MYOKMyoKardia, Inc.PERRY MARK LDirectorOption ExerciseD48.8511,000537,3500
Nov 19 2020MYOKMyoKardia, Inc.PERRY MARK LDirectorOption ExerciseD14.0011,000154,0000
Nov 19 2020MYOKMyoKardia, Inc.PERRY MARK LDirectorOption ExerciseD13.6011,000149,6000
Nov 19 2020MYOKMyoKardia, Inc.PERRY MARK LDirectorOption ExerciseD10.0021,800218,0000
Nov 19 2020MYOKMyoKardia, Inc.PERRY MARK LDirectorSellU0.0029,5080029.5 K to 0 (-100.00 %)
Nov 19 2020MYOKMyoKardia, Inc.PERRY MARK LDirectorOption ExerciseD100.273,000300,8100
Nov 19 2020MYOKMyoKardia, Inc.PERRY MARK LDirectorOption ExerciseD47.776,600315,2820
Nov 19 2020MYOKMyoKardia, Inc.PERRY MARK LDirectorOption ExerciseD48.8511,000537,3500
Nov 19 2020MYOKMyoKardia, Inc.PERRY MARK LDirectorOption ExerciseD14.0011,000154,0000
Nov 19 2020MYOKMyoKardia, Inc.PERRY MARK LDirectorOption ExerciseD13.6011,000149,6000
Nov 19 2020MYOKMyoKardia, Inc.PERRY MARK LDirectorOption ExerciseD10.0021,800218,0000
Nov 19 2020MYOKMyoKardia, Inc.PERRY MARK LDirectorSellU0.0029,5080029.5 K to 0 (-100.00 %)
Jun 22 2020MYOKMyoKardia, Inc.PERRY MARK LDirectorOption ExerciseA0.001,80001,800
Jun 22 2020MYOKMyoKardia, Inc.PERRY MARK LDirectorOption ExerciseA100.273,000300,8103,000
Jun 19 2020GBTGlobal Blood Thera ...PERRY MARK LDirectorOption ExerciseA0.003,03703,037
Jun 19 2020GBTGlobal Blood Thera ...PERRY MARK LDirectorOption ExerciseA0.003,03703,037
Jun 19 2020GBTGlobal Blood Thera ...PERRY MARK LDirectorOption ExerciseA64.755,247339,7435,247
Jun 19 2020GBTGlobal Blood Thera ...PERRY MARK LDirectorOption ExerciseA64.755,247339,7435,247
Jun 19 2020GBTGlobal Blood Thera ...PERRY MARK LDirectorOption ExerciseM0.004,80000
Jun 19 2020GBTGlobal Blood Thera ...PERRY MARK LDirectorOption ExerciseM0.004,80000
Jun 19 2020GBTGlobal Blood Thera ...PERRY MARK LDirectorBuyM0.004,800031,22826.4 K to 31.2 K (+18.16 %)
Jun 19 2020GBTGlobal Blood Thera ...PERRY MARK LDirectorBuyM0.004,800031,22826.4 K to 31.2 K (+18.16 %)
Jun 16 2020MYOKMyoKardia, Inc.PERRY MARK LDirectorOption ExerciseM0.002,30000
Jun 16 2020MYOKMyoKardia, Inc.PERRY MARK LDirectorBuyM0.002,300027,70825.4 K to 27.7 K (+9.05 %)
Jun 12 2020NVDANVIDIA CORPPERRY MARK LDirectorGrantA0.00712012,73512 K to 12.7 K (+5.92 %)
May 29 2020NVDANVIDIA CORPPERRY MARK LDirectorSellS342.73600205,63712,02312.6 K to 12 K (-4.75 %)
May 29 2020NVDANVIDIA CORPPERRY MARK LDirectorSellS341.54300102,46312,62312.9 K to 12.6 K (-2.32 %)
May 29 2020NVDANVIDIA CORPPERRY MARK LDirectorSellS340.38300102,11312,92313.2 K to 12.9 K (-2.27 %)
May 29 2020NVDANVIDIA CORPPERRY MARK LDirectorSellS339.16600203,49413,22313.8 K to 13.2 K (-4.34 %)
May 29 2020NVDANVIDIA CORPPERRY MARK LDirectorSellS338.09600202,85613,82314.4 K to 13.8 K (-4.16 %)
May 29 2020NVDANVIDIA CORPPERRY MARK LDirectorSellS336.97800269,57814,42315.2 K to 14.4 K (-5.26 %)
May 29 2020NVDANVIDIA CORPPERRY MARK LDirectorSellS335.871,202403,71215,22316.4 K to 15.2 K (-7.32 %)
May 29 2020NVDANVIDIA CORPPERRY MARK LDirectorSellS333.45404134,71416,42516.8 K to 16.4 K (-2.40 %)
May 29 2020NVDANVIDIA CORPPERRY MARK LDirectorSellS332.201,100365,42116,82917.9 K to 16.8 K (-6.14 %)
May 29 2020NVDANVIDIA CORPPERRY MARK LDirectorSellS331.312,200728,88617,92920.1 K to 17.9 K (-10.93 %)
May 29 2020NVDANVIDIA CORPPERRY MARK LDirectorSellS330.321,600528,50620,12921.7 K to 20.1 K (-7.36 %)
May 29 2020NVDANVIDIA CORPPERRY MARK LDirectorSellS329.281,300428,06221,72923 K to 21.7 K (-5.65 %)
May 29 2020NVDANVIDIA CORPPERRY MARK LDirectorSellS327.93802263,00223,02923.8 K to 23 K (-3.37 %)
May 29 2020NVDANVIDIA CORPPERRY MARK LDirectorSellS326.51400130,60523,83124.2 K to 23.8 K (-1.65 %)
May 13 2020GBTGlobal Blood Thera ...PERRY MARK LDirectorOption ExerciseM28.4515,000426,7500
May 13 2020GBTGlobal Blood Thera ...PERRY MARK LDirectorOption ExerciseM18.8515,000282,7500
May 13 2020GBTGlobal Blood Thera ...PERRY MARK LDirectorOption ExerciseM20.008,600172,0000
May 13 2020GBTGlobal Blood Thera ...PERRY MARK LDirectorOption ExerciseM20.0015,000300,0000
May 13 2020GBTGlobal Blood Thera ...PERRY MARK LDirectorSellS79.171,295102,52226,42827.7 K to 26.4 K (-4.67 %)
May 13 2020GBTGlobal Blood Thera ...PERRY MARK LDirectorSellS78.6534,6982,728,93227,72362.4 K to 27.7 K (-55.59 %)
May 13 2020GBTGlobal Blood Thera ...PERRY MARK LDirectorSellS77.7113,0241,012,13862,42175.4 K to 62.4 K (-17.26 %)
May 13 2020GBTGlobal Blood Thera ...PERRY MARK LDirectorSellS76.2860045,77175,44576 K to 75.4 K (-0.79 %)
May 13 2020GBTGlobal Blood Thera ...PERRY MARK LDirectorSellS75.431,350101,83376,04577.4 K to 76 K (-1.74 %)
May 13 2020GBTGlobal Blood Thera ...PERRY MARK LDirectorSellS74.012,633194,86577,39580 K to 77.4 K (-3.29 %)
May 13 2020GBTGlobal Blood Thera ...PERRY MARK LDirectorBuyM28.4515,000426,75080,02865 K to 80 K (+23.07 %)
May 13 2020GBTGlobal Blood Thera ...PERRY MARK LDirectorBuyM18.8515,000282,75065,02850 K to 65 K (+29.98 %)
May 13 2020GBTGlobal Blood Thera ...PERRY MARK LDirectorBuyM20.008,600172,00050,02841.4 K to 50 K (+20.76 %)
May 13 2020GBTGlobal Blood Thera ...PERRY MARK LDirectorBuyM20.0015,000300,00041,42826.4 K to 41.4 K (+56.76 %)
Feb 20 2020NVDANVIDIA CORPPERRY MARK LDirectorSellS296.8920059,37824,23124.4 K to 24.2 K (-0.82 %)
Feb 20 2020NVDANVIDIA CORPPERRY MARK LDirectorSellS296.361,459432,38924,43125.9 K to 24.4 K (-5.64 %)
Feb 20 2020NVDANVIDIA CORPPERRY MARK LDirectorSellS295.51505149,23325,89026.4 K to 25.9 K (-1.91 %)
Feb 20 2020NVDANVIDIA CORPPERRY MARK LDirectorSellS294.19400117,67626,39526.8 K to 26.4 K (-1.49 %)
Feb 20 2020NVDANVIDIA CORPPERRY MARK LDirectorSellS292.991,201351,88126,79528 K to 26.8 K (-4.29 %)
Feb 20 2020NVDANVIDIA CORPPERRY MARK LDirectorSellS291.76615179,43227,99628.6 K to 28 K (-2.15 %)
Feb 20 2020NVDANVIDIA CORPPERRY MARK LDirectorSellS290.681,302378,46528,61129.9 K to 28.6 K (-4.35 %)
Feb 20 2020NVDANVIDIA CORPPERRY MARK LDirectorSellS289.682,013583,12629,91331.9 K to 29.9 K (-6.31 %)
Feb 20 2020NVDANVIDIA CORPPERRY MARK LDirectorSellS288.711,057305,16631,92633 K to 31.9 K (-3.20 %)
Jun 20 2019GBTGlobal Blood Thera ...PERRY MARK LDirectorOption ExerciseA0.004,80004,800
Jun 20 2019GBTGlobal Blood Thera ...PERRY MARK LDirectorOption ExerciseA56.307,500422,2507,500
Jun 17 2019MYOKMyoKardia IncPERRY MARK LDirectorOption ExerciseA0.002,30002,300
Jun 17 2019MYOKMyoKardia IncPERRY MARK LDirectorOption ExerciseA47.176,600311,3226,600
May 28 2019NVDANVIDIA CORPPERRY MARK LDirectorGrantA0.001,258032,98331.7 K to 33 K (+3.97 %)
Jun 22 2018GBTGlobal Blood Thera ...PERRY MARK LDirectorOption ExerciseA42.2515,000633,75015,000
Jun 14 2018MYOKMyoKardia IncPERRY MARK LDirectorOption ExerciseA48.8511,000537,35011,000
May 21 2018NVDANVIDIA CORPPERRY MARK LDirectorGrantA0.00963031,72530.8 K to 31.7 K (+3.13 %)
Feb 13 2018NVDANVIDIA CORPPERRY MARK LDirectorSellS227.9317,3073,944,80530,76248.1 K to 30.8 K (-36.00 %)
Aug 16 2017NVDANVIDIA CORPPERRY MARK LDirectorSellS162.2416,2812,641,36948,06964.4 K to 48.1 K (-25.30 %)
Jun 22 2017GBTGlobal Blood Thera ...PERRY MARK LDirectorOption ExerciseA28.4515,000426,75015,000
May 26 2017NVDANVIDIA CORPPERRY MARK LDirectorGrantA0.002,058064,35062.3 K to 64.4 K (+3.30 %)
May 26 2017NVDANVIDIA CORPPERRY MARK LDirectorGiftG0.0010,000040,00050 K to 40 K (-20.00 %)
Jul 15 2016NVDANVIDIA CORPPERRY MARK LDirectorOption ExerciseM17.7835,000622,3000
Jul 15 2016NVDANVIDIA CORPPERRY MARK LDirectorOption ExerciseM17.7835,000622,3000
Jul 15 2016NVDANVIDIA CORPPERRY MARK LDirectorSellS52.9335,0001,852,46362,29297.3 K to 62.3 K (-35.97 %)
Jul 15 2016NVDANVIDIA CORPPERRY MARK LDirectorSellS52.9335,0001,852,46362,29297.3 K to 62.3 K (-35.97 %)
Jul 15 2016NVDANVIDIA CORPPERRY MARK LDirectorBuyM17.7835,000622,30097,29262.3 K to 97.3 K (+56.19 %)
Jul 15 2016NVDANVIDIA CORPPERRY MARK LDirectorBuyM17.7835,000622,30097,29262.3 K to 97.3 K (+56.19 %)
Jun 09 2016MYOKMyoKardia IncPERRY MARK LDirectorOption ExerciseA13.6011,000149,60011,000
May 23 2016NVDANVIDIA CORPPERRY MARK LDirectorGrantA0.006,213062,29256.1 K to 62.3 K (+11.08 %)
Jan 07 2016GBTGlobal Blood Thera ...PERRY MARK LDirectorBuyP20.005,000100,00026,42821.4 K to 26.4 K (+23.33 %)
Nov 16 2015NVDANVIDIA CORPPERRY MARK LDirectorOption ExerciseM12.4640,000498,4000
Nov 16 2015NVDANVIDIA CORPPERRY MARK LDirectorSellS30.4940,0001,219,70456,07996.1 K to 56.1 K (-41.63 %)
Nov 16 2015NVDANVIDIA CORPPERRY MARK LDirectorBuyM12.4640,000498,40096,07956.1 K to 96.1 K (+71.33 %)
Nov 05 2015MYOKMyoKardia IncPERRY MARK LDirectorBuyP10.005,00050,00025,40820.4 K to 25.4 K (+24.50 %)
Oct 30 2015MYOKMyoKardia IncPERRY MARK LDirectorOption ExerciseA10.0021,800218,00021,800
Aug 13 2015GBTGlobal Blood Thera ...PERRY MARK LDirectorOption ExerciseA20.008,600172,0008,600
Aug 13 2015GBTGlobal Blood Thera ...PERRY MARK LDirectorOption ExerciseA20.0015,000300,00015,000
May 26 2015NVDANVIDIA CORPPERRY MARK LDirectorGrantA0.0010,283056,07945.8 K to 56.1 K (+22.45 %)
May 26 2005ABIOARCA biopharma, In ...PERRY MARK LDirectorOption ExerciseA6.7315,000100,95015,000
Mar 25 2005ABIOARCA biopharma, In ...PERRY MARK LDirectorOption ExerciseA6.5025,000162,50025,000
May 10 2004ABIOARCA biopharma, In ...PERRY MARK LDirectorOption ExerciseA11.117,50083,3257,500

Page:   1